Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
Impact
The proposed changes in S1215 are expected to influence state laws surrounding prescription practices and patient privacy significantly. By enabling patients to opt out of prescriptions that could lead to addiction or relapse, this bill aims to enhance the overall integrity of the prescription medication distribution system. Additionally, it imposes new requirements on healthcare providers to engage with patients around these preferences, ensuring clear communication and enhanced patient care. This could lead to alterations in how prescribers approach pain management and treatment strategies for vulnerable populations.
Summary
Senate Bill S1215 seeks to amend the existing prescription monitoring program by allowing patients to express their preference not to be prescribed opioid drugs or other controlled substances with a significant potential for abuse or addiction. This initiative is intended to provide patients with more agency in their treatment options and to enhance their recovery processes, particularly for those with a history of substance abuse. The bill mandates that the Division of Consumer Affairs develop a systematic approach to incorporate patient requests regarding their prescription information, thereby ensuring that such preferences are documented and respected within the monitoring system.
Contention
While many support the bill as a progressive step toward enhancing patient safety and autonomy, some critics may express concerns regarding the logistical implications of implementation. There might be discussions around how effectively healthcare providers can access and act upon these patient preferences, particularly in emergency situations where typical communication channels might be impacted. This legislation may prompt further debate over the balance between patient rights and the medical community's responsibility to manage prescriptions responsibly.
Same As
Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
Carry Over
Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
Carry Over
Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
Requires prescriptions for animals to be issued in name of animal owner; prohibits unnamed persons from possessing prescribed drugs; and requires Prescription Monitoring Program to include information about controlled substances prescribed by veterinarians.
Requires hospital and emergency room physicians to consult the prescription monitoring program registry and to notify a patient's prescriber that such patient is being treated for a controlled substance overdose.
Expands definition of personal data to include use of reproductive health care services and prohibits collection of reproductive health care prescription drugs from Prescription Monitoring Program.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.